BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Nucletron B.V. Releases Comprehensive Film-and Volume-Based Planning System for Wide Variety of Brachy Solutions


5/14/2009 9:52:20 AM

VEENENDAAL, The Netherlands, May 14 /PRNewswire/ -- Nucletron, a knowledge-based leader in radiation oncology, today announced a new release of Oncentra(R) Brachy, a comprehensive film- and volume-based treatment planning system to optimize cancer treatment planning for brachytherapy. Oncentra Brachy, the world's first fully DICOM-compatible treatment planning system, is a user-friendly Windows-based planning system that features state-of-the-art optimization algorithms to ensure efficient treatment.

Oncentra Brachy is adaptable to any clinical workflow. As well as advanced 3D contouring and margining tools, Oncentra Brachy fully supports film-based (2D) treatment planning. The system allows for planning of a wide variety of brachytherapy treatments. Oncentra Brachy is fully geared up towards Intensity Modulated Brachytherapy (IMBT).

"We have set a new benchmark in brachytherapy treatment planning," said Jos Lamers, chief executive officer of Nucletron. "We have worked with our clinical partners to develop a solution that migrates PLATO users to a new platform that fits the demands of all clinics. As part of our full range of brachytherapy solutions, Oncentra Brachy is a key element of our efforts in improving patient care."

Nucletron will display and demonstrate Oncentra Brachy throughout the 2009 GEC ESTRO in Porto, Portugal, from 13 to 16 May 2009, and at ABS 2009 in Toronto, Canada, from 31 May to 2 June 2009.

About Nucletron

Nucletron is a knowledge-based leader in Radiation Oncology, working with clinical teams to realize innovative solutions that improve patient care. Nucletron strives to offer the best possible choice of radiation modalities through integrated products, software and services. Critical to the Nucletron philosophy is the establishment of close working relationships with individual clinical teams - reconfiguring traditional boundaries between customer and solution provider. Many Nucletron employees have clinical experience delivering oncology care, providing an in-depth understanding of the complex needs of clinicians. For more information, visit http://www.nucletron.com.

CONTACT: Media Contact: Danielle Davis, +1-443-834-6725,
ddavis@rosecomm.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES